1. Home
  2. LGND vs ACHC Comparison

LGND vs ACHC Comparison

Compare LGND & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$299.86

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Acadia Healthcare Company Inc.

ACHC

Acadia Healthcare Company Inc.

HOLD

Current Price

$34.67

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGND
ACHC
Founded
1987
2005
Country
United States
United States
Employees
68
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.1B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
LGND
ACHC
Price
$299.86
$34.67
Analyst Decision
Strong Buy
Buy
Analyst Count
7
15
Target Price
$256.29
$22.67
AVG Volume (30 Days)
354.1K
3.2M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$3,312,769,000.00
Revenue This Year
$1.25
$5.08
Revenue Next Year
$19.41
$5.98
P/E Ratio
$76.27
$680.20
Revenue Growth
N/A
5.04
52 Week Low
$131.67
$11.43
52 Week High
$326.63
$35.83

Technical Indicators

Market Signals
Indicator
LGND
ACHC
Relative Strength Index (RSI) 54.03 67.18
Support Level $290.20 $22.52
Resistance Level $326.63 N/A
Average True Range (ATR) 10.96 1.50
MACD -3.74 0.12
Stochastic Oscillator 24.94 80.02

Price Performance

Historical Comparison
LGND
ACHC

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.

Share on Social Networks: